Jason Wilson, MD
Emergency Medicine · Tampa, FLNPI 1811159452
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $346,157 of the $538,456 with a category attached, or 64.3%. 19 manufacturers reported payments, led by Johnson & Johnson at 32.6% of the total. Reporting peaked in 2022 at $133,729 and has fallen 78.1% since, to $29,267 in 2025. Among emergency medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 502 payments — averaging $1072.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$176K
- AstraZeneca$138K
- Gilead$81K
- Portola Pharmaceuticals, LLC$38K
- Pfizer$23K
- Paratek Pharmaceuticals, Inc.$22K
- plus $62K from 13 others
Across 109 payments — averaging $3429.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$192K
- Acelrx Pharmaceuticals, Inc.$82K
- AbbVie$59K
- Portola Pharmaceuticals, LLC$35K
- Boehringer Ingelheim Canada Ltd.ltee$6K
What the payments were for
- Consulting fees$117,65222%
- Speaking & faculty fees$346,15764%
- Travel & lodging$61,60511%
- Food & beverage$12,8862%
- Education$90%
- Gifts$1470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 175 | $175,509 |
| AstraZeneca(2 entities) | 160 | $137,830 |
| Gilead | 33 | $80,616 |
| Portola Pharmaceuticals, LLC | 34 | $37,505 |
| Pfizer | 24 | $22,671 |
| Paratek Pharmaceuticals, Inc. | 22 | $22,266 |
| Acelrx Pharmaceuticals, Inc. | 14 | $16,861 |
| Abbott | 9 | $15,694 |
| Biomerieux Inc | 4 | $11,177 |
| Indivior Inc. | 9 | $6,592 |
| Eagle Pharmaceuticals, Inc. | 7 | $4,281 |
| E.r. Squibb & Sons, L.L.C. | 2 | $3,596 |
| Cepheid | 1 | $3,500 |
| Memed US, Inc. | 2 | $147 |
| Heartflow, Inc. | 1 | $116 |
| Lilly USA, LLC | 2 | $33 |
| Pear Therapeutics (US), Inc. | 1 | $28 |
| AbbVie | 1 | $21 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$538,456 in reported general payments places this provider in the 95th percentile of 3,289 emergency medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other emergency medicine in Tampa
- Juan GallegoTampa$73K
- David WeinTampa$22K
- Pushpal BanerjeeTampa$20K
- Rodolfo LoureiroTampa$7K
- Michael LozanoTampa$5K
- Laurent DreyfussSunrise$1.2M
- Robert LutenJacksonville$190K
- Adam LeisyHialeah$148K
- Joseph TyndallGainesville$130K
- Kunal AgarwalMiami$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.